| 1 |
32499732 | Pharmacological Treatment of Anxiety Disorders: The Role of the HPA Axis. | 2020 |
1 |
| 2 |
12919154 | Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans. | 2003 Sep |
1 |
| 3 |
12035937 | Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans. | 2002 May |
1 |
| 4 |
10443648 | The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans. | 1999 Aug |
2 |
| 5 |
9663654 | Inhibition of naloxone-stimulated adrenocorticotropin release by alprazolam in myotonic dystrophy patients. | 1998 May |
2 |
| 6 |
7883836 | The effect of alprazolam on serum cortisol and luteinizing hormone pulsatility in normal women and in women with stress-related anovulation. | 1995 Mar |
3 |
| 7 |
8027217 | Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans. | 1994 Jul |
3 |
| 8 |
8082875 | The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam. | 1994 Apr |
1 |
| 9 |
8298983 | Benzodiazepines antagonize central corticotropin releasing hormone-induced suppression of natural killer cell activity. | 1993 Dec 17 |
1 |